The two-day FDA public hearing on regulated medical products using the internet and social media began this morning. While the hearing is mostly an opportunity for companies and interested parties to present their ideas and opinions to the FDA, the FDA panel is asking questions of some of the speakers, and from their questions it seems they are most interested in those speakers who are presenting ideas for recommendations rather than just rehashing the importance of the Internet for patients and for communicating public health information.
The coverage can be watched via webcast at http://www.capitolconnection.net/capcon/fda/111209/FDAlive.htm
The Twitterverse is exploding using the hashtag #fdasm.
If you want to follow my commentary, I'm tweeting from @emilydownward
More to come.